COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January–30 June 2021)

COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January–30 June 2021)

Observational studies are needed to demonstrate real-world vaccine effectiveness (VE) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outcomes. Our objective was to conduct a review of published SARS-CoV-2 VE articles, supplemented by preprints, during the first 6 months of COVI...

Full description

Bibliographic Details
Main Authors:	Sarah M. Hatcher, Stacy M. Endres-Dighe, Frederick J. Angulo, Amit Srivastava, Jennifer L. Nguyen, Farid Khan, Catherine Martin, David L. Swerdlow, John M. McLaughlin, Nneka Ubaka-Blackmore, Linda Morris Brown
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Vaccines
Subjects:	COVID-19 vaccines vaccine effectiveness observational studies review literature SARS-CoV-2 BNT162b2 vaccine
Online Access:	https://www.mdpi.com/2076-393X/10/3/393

Similar Items

Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report
by: Eun-Ju Kim, et al.
Published: (2023-06-01)

Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
by: Cynthia M. Rohde, et al.
Published: (2023-02-01)

Eosinophilic Granulomatosis with Polyangiitis Relapse after COVID-19 Vaccination: A Case Report
by: Giulia Costanzo, et al.
Published: (2021-12-01)

Effectiveness of BNT162b2 COVID-19 Vaccine in Preventing Severe Symptomatic Infection among Healthcare Workers
by: Efrén Murillo-Zamora, et al.
Published: (2021-07-01)

Impact of Health Workers’ Choice of COVID-19 Vaccine Booster on Immunization Levels in Istanbul, Turkey
by: Meryem Merve Ören, et al.
Published: (2023-05-01)

Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine
by: Itzchak Levy, et al.
Published: (2022-07-01)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
by: Chayanit Mahasing, et al.
Published: (2023-03-01)

Effectiveness of Vaccination in Preventing COVID-19: A Community Study Comparing Four Vaccines
by: Zoran Kokić, et al.
Published: (2023-02-01)

Immune Response in Regard to Hypersensitivity Reactions after COVID-19 Vaccination
by: Ming-Hsiu Hsieh, et al.
Published: (2022-07-01)

Prediction and detection of side effects severity following COVID-19 and influenza vaccinations: utilizing smartwatches and smartphones
by: Yosi Levi, et al.
Published: (2024-03-01)

Genomic Transcriptome Benefits and Potential Harms of COVID-19 Vaccines Indicated from Optimized Genomic Biomarkers
by: Zhengjun Zhang
Published: (2022-10-01)

Anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese hemodialysis patients
by: Keiji Hirai, et al.
Published: (2024-05-01)

Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis
by: Eli Magen, et al.
Published: (2022-07-01)

COVID-19 Vaccination and Acute Anterior Uveitis—A Case Control Study
by: Asaf Shemer, et al.
Published: (2025-02-01)

Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult
by: Mazin Barry, et al.
Published: (2022-01-01)

Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign
by: Soha Albayat, et al.
Published: (2023-05-01)

Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden
by: Vibeke Manniche, et al.
Published: (2024-08-01)

Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event
by: Nikolaos Syrigos, et al.
Published: (2022-05-01)

Attitudes of family medicine residents in Ankara towards COVID-19 vaccines administered in Turkey: a descriptive, cross-sectional study
by: Hüsna Sarıca Çevik, et al.
Published: (2022-06-01)

Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?
by: Hamid A. Merchant
Published: (2022-12-01)

Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV
by: Wang-Da Liu, et al.
Published: (2024-08-01)

Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report
by: Tzu-Chien Lin, et al.
Published: (2023-06-01)

Durability of Protection Post–Primary COVID-19 Vaccination in the United States
by: Amanda Zheutlin, et al.
Published: (2022-09-01)

Systemic COVID-19 Vaccination Enhances the Humoral Immune Response after SARS-CoV-2 Infection: A Population Study from a Hospital in Poland Criteria for COVID-19 Reimmunization Are Needed
by: Piotr Kosiorek, et al.
Published: (2022-02-01)

Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns
by: Matteo Nioi, et al.
Published: (2021-11-01)

Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults
by: Hagit Kopel, et al.
Published: (2023-11-01)

Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey
by: Makoto Yoshida, et al.
Published: (2022-03-01)

Pre-graft vaccination or infection do not decrease COVID-19 infections in recipients of allogeneic stem cell transplantation vaccinated and/or protected by immunotherapy after transplant
by: Valentin Letailleur, et al.
Published: (2024-12-01)

Safety and Immunogenicity of a Single Dose of BNT162b2 COVID-19 mRNA Vaccine in a Warfarin-Treated Protein S Deficient Patient: A Case Report and Literature Review
by: Cucunawangsih Cucunawangsih, et al.
Published: (2022-12-01)

The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation
by: Marika Watanabe, et al.
Published: (2022-01-01)

Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformResearch in context
by: Jennifer L. Nguyen, et al.
Published: (2025-01-01)

Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study
by: Hakan Demirhindi, et al.
Published: (2022-04-01)

Association between Immunoglobulin G Levels and Adverse Effects Following Vaccination with the BNT162b2 Vaccine among Japanese Healthcare Workers
by: Jun Otani, et al.
Published: (2021-10-01)

Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccineResearch in context
by: Ivan Odak, et al.
Published: (2024-01-01)

BNT162b2 COVID-19 Vaccination and Its Effect on Blood Pressure
by: Toh Leong Tan, et al.
Published: (2022-12-01)

Endurance Exercise Does Not Exacerbate Cardiac Inflammation in BALB/c Mice Following mRNA COVID-19 Vaccination
by: Sander Eens, et al.
Published: (2024-08-01)

Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent
by: Pimchanok Kulsirichawaroj, et al.
Published: (2022-01-01)

Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination
by: Ariel Israel, et al.
Published: (2022-04-01)

Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
by: Selina Kikkenborg Berg, et al.
Published: (2022-11-01)

A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination
by: Prachi Saluja, et al.
Published: (2022-09-01)